Interestingly, it was found that NKT cells from cancer patients produce reduced amounts of IFN-γ than healthy subjects [37], while simvastatin targeted delivery to LSECs activated NKT cells and induced IFN-γ production, which contributed to anti-tumor effect. This evidence concerns the gene IFNG and cancer.